PAUL MONACO: Open Payments
NPI 1366436537 · HAMDEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$456 in 18 payments from 9 companies in 2025. Trend: 2023 $171 · 2024 $398 · 2025 $456
Food & beverage: $456
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $115 |
| Amgen Inc. | 3 | $80 |
| Lilly USA, LLC | 3 | $63 |
| ANI Pharmaceuticals, Inc. | 2 | $56 |
| Novo Nordisk Inc | 2 | $47 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| Amneal Pharmaceuticals LLC | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
Products named: TREMFYA, EVENITY, PURIFIED CORTROPHIN GEL, Wegovy, MOUNJARO, ORENCIA, UNITHROID, ZEPBOUND.
Industry payments across CT — which companies pay providers there.
